… of adults in all phases of chronic myeloid leukemia (CML) with … chromosome positive acute
lymphoblastic leukemia (Ph+ ALL… advised to avoid becoming pregnant while taking dasatinib. …

… Imatinib, dasatinib and nilotinib are considered teratogenic and the use of TKI therapy during
pregnancy … When use occurs in the male partner, however, these outcomes have not been …

… The therapeutic approach to Chronic Myeloid Leukemia (CML… by the second generation TKIs
dasatinib, nilotinib, and, finally… a few pediatric patients discontinued TKI successfully [37,38]…

… Dasatinib and bosutinib are also more potent than imatinib … However, if delivery or processing
of the sample is delayed, or the … success of the TFR approach in chronic myeloid leukemia …

… Management of pregnant chronic myeloid leukemia patients. Expert Review of Hematology.
… Experience with dasatinib and nilotinib use in pregnancy. J Oncol Pharm Pract. 2018; 24: …

… significantly effective drugs in the treatment of chronic myeloid leukemia; and, hence, the …
: the effects of imatinib and nilotinib during pregnancy on hematological and biochemical …

… Philadelphia chromosome in chronic myeloid leukemia (CML) … For example, one may wish
to avoid dasatinib in patients … The rate of successful TFR for patients receiving treatment for …

… of persistent DMR after discontinuation of first-line dasatinib … , and patients with stable NK
cells were more successful in … the other hand, it could deliver signals to NK cells following the …

… therapy for patients with chronic myeloid leukemia (CML) has … strong predictors of TFR success,
3 while factors such as … , nilotinib, dasatinib, and bosutinib, dasatinib was associated with …

… during pregnancy, delivery timing should be coordinated with therapies to avoid cytopenias
at delivery… If needed, platelets may be transfused to > 30,000/µL for a vaginal delivery or to > …